5x5Gy
Showing 1 - 25 of >10,000
Recurrent Glioblastoma Multiforme Trial in Sao Paulo (Stereotactic hypofractionated RT 5x5Gy, Stereotactic hypofractionated RT
Active, not recruiting
- Recurrent Glioblastoma Multiforme
- Stereotactic hypofractionated RT 5x5Gy
- Stereotactic hypofractionated RT 5x7Gy
-
Sao Paulo, SP, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021
Renal Cancer Trial in Dijon, Pierre Bénite (Stereotactic radiotherapy 4 x 8 Gy, Stereotactic radiotherapy 5 x 8 Gy, Stereotactic
Active, not recruiting
- Renal Cancer
- Stereotactic radiotherapy 4 x 8 Gy
- +3 more
-
Dijon, France
- +1 more
Jan 26, 2022
Locally Advanced Rectal Adenocarcinoma Trial in United States (APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and
Recruiting
- Locally Advanced Rectal Adenocarcinoma
- APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days
- mFOLFOX and Radiation Therapy 5Gy x 5 days
-
Winston-Salem, North Carolina
- +2 more
Sep 14, 2021
Rectal Cancer Stage III Trial in Germany (Oxaliplatin, 85 mg/m2, 5FU; 2400 mg/m2, 5FU, 250 mg/m2)
Recruiting
- Rectal Cancer Stage III
- Oxaliplatin, 85 mg/m2
- +11 more
-
Esslingen, Baden-Wuerttemberg, Germany
- +75 more
Dec 13, 2022
Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)
Active, not recruiting
- Breast Cancer
- DCIS
- APBI: 30 Gy
- APBI: 27.5 Gy
-
Barrie, Ontario, Canada
- +9 more
Apr 4, 2022
NSCLC, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer Trial (Palliative Radiotherapy: 5 x 4Gy, chemo +
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- Palliative Radiotherapy: 5 x 4Gy
- chemotherapy + immune checkpoint inhibitors
- (no location specified)
Jun 27, 2022
Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)
Unknown status
- Sarcoma
- +16 more
- Sequential chemotherapy - 3 courses of AI
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021
Breast Cancer Trial in Portland (biological, drug, radiation)
Recruiting
- Breast Cancer
- DPX-Survivac
- +3 more
-
Portland, OregonProvidence Portland Medical Center
Oct 19, 2021
Spinal Metastases Trial in Australia, Canada (20 Gy in 5 fractions, Conventional SBRT: 24 Gy in 2 fractions)
Completed
- Spinal Metastases
- 20 Gy in 5 fractions
- Conventional SBRT: 24 Gy in 2 fractions
-
Grafton, Aucklund, Australia
- +21 more
Aug 16, 2021
Prostate Cancer Trial in Kuopio (Hypofractionated RT 5 x 7,25 Gy, LDR-brachytherapy with I125 seeds)
Active, not recruiting
- Prostate Cancer
- Hypofractionated RT 5 x 7,25 Gy
- LDR-brachytherapy with I125 seeds
-
Kuopio, FinlandKuopio University Hospital
Feb 17, 2021
Arthrosis, Osteoarthritis Trial (low dose radiotherapy (0.5 Gy), mock radiation treatment, low dose radiotherapy (1.0 Gy))
Not yet recruiting
- Arthrosis
- Osteoarthritis
- low dose radiotherapy (0.5 Gy)
- +2 more
- (no location specified)
May 31, 2023
Spinal Cord Compression Due to Metastasis to Spine Trial in Lubeck Hansestadt (High-precision RT 5x5 Gy in 1 week)
Completed
- Spinal Cord Compression Due to Metastasis to Spine
- High-precision RT 5x5 Gy in 1 week
-
Lubeck Hansestadt, GermanyDepartment of Radiation Oncology, University of Lübeck and Unive
Feb 18, 2020
Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy
Suspended
- Resectable Head and Neck Squamous Cell Carcinoma
- 42 Gy Radiation Therapy
- +2 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jan 13, 2023
Prostate Cancer Trial in Toronto (Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5)
Active, not recruiting
- Prostate Cancer
- Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5
-
Toronto, Ontairo, CanadaSunnybrook Health Sciences Center
Sep 27, 2022
Colorectal Cancer Metastatic Trial in Adelaide (CNA3103: 5 x 10^7 cells, CNA3103: 1.5 x 10^8 cells, CNA3103: 4.5 x 10^8 cells)
Not yet recruiting
- Colorectal Cancer Metastatic
- CNA3103: 5 x 10^7 cells
- +4 more
-
Adelaide, South Australia, AustraliaCarina Biotech Investigators
Feb 26, 2023
X-Linked Retinitis Pigmentosa Trial in Meguro-ku (AAV5-hRKp.RPGR)
Not yet recruiting
- X-Linked Retinitis Pigmentosa
- AAV5-hRKp.RPGR
-
Meguro-ku, JapanNational Hospital Organization Tokyo Medical Center
Jun 23, 2023
Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy
Recruiting
- Breast Neoplasms
- Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 1, 2022
Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Short course radiotherapy with concurrent capecitabine(825mg/m2)
- Long course radiotherapy with concurrent capecitabine(825mg/m2)
- (no location specified)
Jun 24, 2023
HPV-Associated Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Neck Trial in United States (diagnostic
Recruiting
- HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Squamous Cell Carcinoma of the Neck
- F-FMISO PET/CT Scan
- +5 more
-
Hartford, Connecticut
- +9 more
Jan 31, 2023
Quality of Life Trial in Newcastle (Leg Press Resistance Training (3x5), Leg Press Resistance Training (5x5))
Recruiting
- Quality of Life
- Leg Press Resistance Training (3x5)
- Leg Press Resistance Training (5x5)
-
Newcastle, Tyne And Wear, United KingdomNorthumbria University
Nov 6, 2023
Prostatic Adenocarcinoma Trial in France (Moderate hypofractionated radiotherapy, Stereotactic radiotherapy)
Completed
- Prostatic Adenocarcinoma
- Moderate hypofractionated radiotherapy
- Stereotactic radiotherapy
-
Albi, France
- +6 more
Mar 2, 2022
Emergency Department Discharge for Type II Supracondylar
Not yet recruiting
- Supracondylar Fracture
- Interview
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 28, 2023
Prostate Cancer Trial in United States (stereotactic body radiation therapy (SBRT)- 45 Gy, stereotactic body radiation therapy
Active, not recruiting
- Prostate Cancer
- stereotactic body radiation therapy (SBRT)- 45 Gy
- +3 more
-
Aurora, Colorado
- +4 more
Mar 23, 2022
Alzheimer's Disease Trial in Richmond (10 GY in 5 daily fractions, 20 GY in 10 daily fractions)
Terminated
- Alzheimer's Disease
- 10 GY in 5 daily fractions
- 20 GY in 10 daily fractions
-
Richmond, VirginiaVirginia Commonwealth University
Nov 18, 2021